Valuation: Coral Laboratories Limited

Market Cap 1.32B 13.88M 12.04M 11.23M 10.32M 19.53M 19.7M 132M 51.69M 660M 52.13M 50.98M 2.19B P/E 2024
8.4x
P/E 2025 10.4x
Enterprise Value 1.05B 11.01M 9.55M 8.9M 8.19M 15.49M 15.63M 105M 40.99M 523M 41.35M 40.44M 1.74B EV / Sales 2024
1.25x
EV / Sales 2025 1.94x
Free-Float
19.97%
Yield 2024
0.54%
Yield 2025 0.21%
1 day+3.07%
1 week+3.39%
Current month+0.11%
1 month-5.05%
3 months+35.31%
6 months+26.07%
Current year+31.13%
1 week 547.95
Extreme 547.95
583
1 month 547.95
Extreme 547.95
620
Current year 360
Extreme 360
659
1 year 360
Extreme 360
659
3 years 245.15
Extreme 245.15
999
5 years 217
Extreme 217
999
10 years 81.2
Extreme 81.2
1,190
Manager TitleAgeSince
Director of Finance/CFO 49 2017-05-25
Director TitleAgeSince
Director/Board Member 45 2017-05-25
Director/Board Member 49 2017-05-25
Director/Board Member 40 2019-05-27
Change 5-day change 1-year change 3-year change Capi.($)
+3.07%+3.39%+0.05%+128.86% 20.91M
-0.51%-6.83%+46.35%+148.39% 1T
+0.20%-4.14%+52.35%+49.40% 613B
-0.53%-5.10%+24.88%+63.57% 433B
+0.48%-0.67%+39.13%+34.00% 350B
+0.08%-3.05%+32.29%+39.91% 292B
+2.09%-8.91%+5.73%+7.71% 239B
+1.75%-5.79%-0.39%-42.69% 206B
+2.94%+3.66%+31.37%+69.06% 204B
+3.13%+3.62%+19.50%+79.07% 163B
Average +1.01%-3.46%+25.13%+57.73% 350.05B
Weighted average by Cap. +0.64%-4.34%+35.20%+71.36%

Financials

2024 2025
Net sales 837M 8.77M 7.61M 7.1M 6.52M 12.34M 12.45M 83.47M 32.66M 417M 32.95M 32.22M 1.38B 1.15B 12.06M 10.46M 9.75M 8.97M 16.97M 17.12M 115M 44.9M 573M 45.29M 44.29M 1.9B
Net income 158M 1.66M 1.44M 1.34M 1.23M 2.33M 2.35M 15.75M 6.16M 78.72M 6.22M 6.08M 261M 242M 2.53M 2.2M 2.05M 1.88M 3.56M 3.6M 24.1M 9.43M 120M 9.51M 9.3M 400M
Net Debt -278M -2.91M -2.53M -2.36M -2.17M -4.1M -4.14M -27.72M -10.85M -139M -10.94M -10.7M -460M -274M -2.87M -2.49M -2.32M -2.14M -4.04M -4.08M -27.33M -10.69M -137M -10.79M -10.55M -453M
Logo Coral Laboratories Limited
Coral Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in the business of pharmaceutical formulations. The Company is engaged in the manufacturing of generic - branded, nutraceuticals, over the counter (OTC), and herbal medicines. It offers dosage forms, which include tablets, capsules, liquid orals, injections (liquids and powder), ointment and creams, gels and lotions, and suppositories. Its product categories include nutraceutical, OTC, sterile and non-sterile. Its nutraceutical products include DAX 200, DAX 400 Drops, Zest drops, and Super Zestcal Tablets. Its OTC products include herbal range, skin care, medical devices, and effervescent range. Its sterile products include small volume liquid - injectables, lyophilized range - injectables, eye drops, and eardrops. Its non-sterile antibiotics/antibacterials, antifungals, gastro-intestinal drugs, anti-emetics, and muscle relaxants. The Company also exports its products to various countries.
Employees
197
Date Price Change Volume
26-08-04 ₹575.00 +3.07% 391
26-08-03 ₹557.90 -2.86% 288
26-07-31 ₹574.35 -0.97% 387
26-07-30 ₹580.00 +4.46% 1,283
26-07-29 ₹555.25 -3.73% 622
  1. Stock Market
  2. Stocks
  3. CORALAB6 Stock